Ayala Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ayala Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q1 2024.
  • Ayala Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending April 8, 2024 was 42.6M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 42.6M Apr 8, 2024 10-K/A 2024-04-26
Q3 2023 10.8M +8.94M +492% Nov 11, 2023 10-Q 2023-11-20
Q2 2023 4.84M +3.02M +166% May 23, 2023 10-Q 2023-05-23
Q4 2022 4.84M -141M -96.7% Jan 31, 2023 10-K 2023-02-10
Q3 2022 1.82M -144M -98.8% Sep 9, 2022 10-Q 2022-09-13
Q2 2022 1.82M -144M -98.8% Jun 7, 2022 10-Q 2022-06-08
Q1 2022 146M +26.2M +21.9% Mar 16, 2022 10-Q 2022-03-17
Q4 2021 146M +33.7M +30.1% Feb 10, 2022 10-K 2022-02-14
Q3 2021 146M +79.4M +120% Sep 7, 2021 10-Q 2021-09-10
Q2 2021 146M +84M +136% Jun 7, 2021 10-Q 2021-06-14
Q1 2021 119M +59.2M +98.3% Mar 8, 2021 10-Q 2021-03-16
Q4 2020 112M +61.8M +123% Jan 15, 2021 10-K 2021-01-22
Q3 2020 66.2M +41.5M +168% Sep 2, 2020 10-Q 2020-09-10
Q2 2020 61.6M +53.6M +668% Jun 11, 2020 10-Q 2020-06-11
Q1 2020 60.2M -9.5M -13.6% Feb 29, 2020 10-Q 2020-03-13
Q4 2019 50.2M -19.5M -28% Dec 16, 2019 10-K 2019-12-20
Q3 2019 24.7M -28.1M -53.2% Sep 6, 2019 10-Q 2019-09-09
Q2 2019 8.02M -44.6M -84.8% Jun 3, 2019 10-Q 2019-06-10
Q1 2019 69.7M +17.4M +33.3% Feb 28, 2019 10-Q 2019-03-12
Q4 2018 69.7M +28.4M +68.8% Dec 31, 2018 10-K 2019-01-11
Q3 2018 52.8M +11.8M +28.6% Aug 31, 2018 10-Q 2018-09-10
Q2 2018 52.6M +12.2M +30% Jun 4, 2018 10-Q 2018-06-07
Q1 2018 52.3M +12M +29.8% Mar 8, 2018 10-Q 2018-03-12
Q4 2017 41.3M +1.16M +2.88% Dec 15, 2017 10-K 2017-12-21
Q3 2017 41.1M +1.22M +3.07% Aug 31, 2017 10-Q 2017-09-11
Q2 2017 40.5M +6.12M +17.8% Jun 2, 2017 10-Q 2017-06-06
Q1 2017 40.3M +6.19M +18.2% Mar 7, 2017 10-Q 2017-03-10
Q4 2016 40.1M +6.38M +18.9% Jan 5, 2017 10-K 2017-01-09
Q3 2016 39.8M +6.48M +19.4% Aug 31, 2016 10-Q 2016-09-08
Q2 2016 34.3M +2.95M +9.4% Jun 1, 2016 10-Q 2016-06-08
Q1 2016 34.1M +6.89M +25.3% Feb 24, 2016 10-Q 2016-02-26
Q4 2015 33.8M +10.1M +42.8% Jan 7, 2016 10-K 2016-01-08
Q3 2015 33.4M +13.8M +70.9% Sep 9, 2015 10-Q 2015-09-11
Q2 2015 31.4M +12.1M +62.9% Jun 10, 2015 10-Q 2015-06-15
Q1 2015 27.2M +13.2M +94.1% Mar 9, 2015 10-Q 2015-03-13
Q4 2014 23.6M +9.77M +70.4% Dec 26, 2014 10-K 2015-01-06
Q3 2014 19.5M +14.5M +288% Sep 2, 2014 10-Q 2014-09-09
Q2 2014 19.3M -577M -96.8% Jun 3, 2014 10-Q 2014-06-10
Q1 2014 14M -522M -97.4% Mar 13, 2014 10-Q 2014-03-17
Q4 2013 13.9M -488M -97.2% Jan 17, 2014 10-K 2014-01-29
Q3 2013 5.02M -387M -98.7% Sep 6, 2013 10-Q 2013-09-16
Q2 2013 596M +232M +63.9% Jun 7, 2013 10-Q 2013-06-14
Q1 2013 536M +250M +87.3% Mar 19, 2013 10-Q/A 2013-03-25
Q4 2012 502M +233M +86.3% Feb 13, 2013 10-K/A 2013-02-14
Q3 2012 392M +150M +62.2% Sep 22, 2012 10-Q/A 2012-10-04
Q2 2012 363M Jun 11, 2012 10-Q/A 2012-10-18
Q1 2012 286M Mar 9, 2012 10-Q/A 2012-10-18
Q4 2011 269M Jan 9, 2012 10-K 2012-01-26
Q3 2011 242M Sep 5, 2011 10-Q 2011-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.